Skip to main content

Market Overview

Moderna And Xilinx Lead The S&P 500 Higher Monday

Moderna And Xilinx Lead The S&P 500 Higher Monday

U.S. indices were trading higher Monday as investors await the Fed's Jackson Hole Economic Policy Symposium this week. FDA approval of Pfizer's (NYSE: PFE) COVID-19 vaccine has also possibly lifted sentiment amid growing COVID-19 concerns.

  • The SPDR S&P 500 ETF Trust (NASDAQ: SPY) gained 0.88% to $447.25
  • The SPDR Dow Jones Industrial Average ETF Trust (NASDAQ: DIA) gained 0.65% to $353.45
  • The Invesco QQQ Trust Series 1 (NASDAQ: QQQ) finished higher by 1.5% to $373.23

Here are the day's winners and losers from the SPY, according to data from Benzinga Pro.

Moderna Inc (NASDAQ: MRNA), Xilinx, Inc. (NASDAQ: XLNX) and Occidental Petroleum Corporation (NYSE: OXY) were among the top gainers for the S&P 500.

Pool Corporation (NASDAQ: POOL), Xcel Energy Inc (NASDAQ: XEL) and Ameren Corp (NYSE: AEE) were among the top losers for the SPY.

Elsewhere On The Street

Payments behemoth Visa Inc. (NYSE: V) acquired a blockchain collectible non-fungible token (NFT) for $150,000 as it makes its first moves in this nascent space… Read More

A recovery for airline companies is in the works. The industry accrued a total of $4.1 billion in July ticket sales — a 947% increase compared with the prior year’s numbers… Read More
Tesla Inc.'s (NASDAQ: TSLA) Model Y vehicle, an all-electric crossover utility vehicle, was announced in March 2019, with first deliveries from the Fremont, California, factory beginning a year later… Read More


Related Articles (SPY)

View Comments and Join the Discussion!

Posted-In: News After-Hours Center Markets Movers Trading Ideas

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at